Serum phosphate is associated with aortic valve calcification in the Multi-ethnic Study of Atherosclerosis (MESA)

Atherosclerosis

Volumn 233, Issue 2, 2014, Pages 331-337

  Linefsky, Jason P ^a   O'Brien, Kevin D ^b   Sachs, Michael ^c   Katz, Ronit ^c   Eng, John ^d   Michos, Erin D ^d   Budoff, Matthew J ^e   De Boer, Ian ^c   Kestenbaum, Bryan ^c  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

^d JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e HARBOR UCLA MEDICAL CENTER   (United States)

Author keywords

Aortic valve; Calcification; Phosphate

Indexed keywords

FIBROBLAST GROWTH FACTOR 23; PARATHYROID HORMONE; PHOSPHATE; BIOLOGICAL MARKER; FIBROBLAST GROWTH FACTOR;

ADULT; AGED; AORTA VALVE CALCIFICATION; AORTA VALVE DISEASE; ARTICLE; ATHEROSCLEROSIS; BLOOD LEVEL; CALCIFICATION; COMPUTER ASSISTED TOMOGRAPHY; DISEASE ASSOCIATION; ETHNICITY; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PARATHYROID HORMONE BLOOD LEVEL; PHOSPHATE BLOOD LEVEL; PHOSPHATE METABOLISM; PHOSPHATE URINE LEVEL; PRIORITY JOURNAL; VERY ELDERLY; AORTA VALVE; AORTA VALVE STENOSIS; BLOOD; CALCINOSIS; CLINICAL TRIAL; EPIDEMIOLOGY; ETHNIC GROUP; ETHNOLOGY; MULTICENTER STUDY; PATHOLOGY; PROSPECTIVE STUDY; RADIOGRAPHY; RISK FACTOR; SEVERITY OF ILLNESS INDEX; SINGLE BLIND PROCEDURE; SOCIOECONOMICS; UNITED STATES; URINE;

AGED; AORTIC VALVE; AORTIC VALVE STENOSIS; BIOLOGICAL MARKERS; CALCINOSIS; ETHNIC GROUPS; FEMALE; FIBROBLAST GROWTH FACTORS; HUMANS; MALE; MIDDLE AGED; PARATHYROID HORMONE; PHOSPHATES; PROSPECTIVE STUDIES; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SINGLE-BLIND METHOD; SOCIOECONOMIC FACTORS; TOMOGRAPHY, X-RAY COMPUTED; UNITED STATES;

EID: 84896291778     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2013.12.051     Document Type: Article

References (42)

1. Otto C., Lind B., Kitzman D., Gersh B., Siscovick D. Association of aortic-valve sclerosis with cardiovascular mortality and morbidity in the elderly. NEngl J Med 1999, 341:142-147.
2. Owens D.S., Budoff M.J., Katz R., et al. Aortic valve calcium independently predicts coronary and cardiovascular events in a primary prevention population. JACC Cardiovasc Imaging 2012, 5:619-625.
3. Rosenhek R., Binder T., Porenta G., et al. Predictors of outcome in severe, asymptomatic aortic stenosis. NEngl J Med 2000, 343:611-617.
4. Cowell S., Newby D., Burton J., et al. Aortic valve calcification on computed tomography predicts the severity of aortic stenosis. Clin Radiol 2003, 58:712-716.
5. Cueff C., Serfaty J.M., Cimadevilla C., et al. Measurement of aortic valve calcification using multislice computed tomography: correlation with haemodynamic severity of aortic stenosis and clinical implication for patients with low ejection fraction. Heart 2011, 97:721-726.
6. Rajamannan N.M., Evans F.J., Aikawa E., et al. Calcific aortic valve disease: not simply a degenerative process: a review and agenda for research from the National Heart and Lung and Blood Institute Aortic Stenosis Working Group. Executive summary: calcific aortic valve disease-2011 update. Circulation 2011, 124:1783-1791.
7. Otto C., Kuusisto J., Reichenbach D., Gown A., O'Brien K. Characterization of the early lesion of 'degenerative' valvular aortic stenosis. Histological and immunohistochemical studies. Circulation 1994, 90:844-853.
8. Chan K.L., Teo K., Dumesnil J.G., Ni A., Tam J., Investigators A. Effect of Lipid lowering with rosuvastatin on progression of aortic stenosis: results of the aortic stenosis progression observation: measuring effects of rosuvastatin (ASTRONOMER) trial. Circulation 2010, 121:306-314.
9. Rossebø A., Pedersen T., Boman K., et al. Intensive lipid lowering with simvastatin and ezetimibe in aortic stenosis. NEngl J Med 2008, 359:1343-1356.
10. Cowell S., Newby D., Prescott R., et al. Arandomized trial of intensive lipid-lowering therapy in calcific aortic stenosis. NEngl J Med 2005, 352:2389-2397.
11. Mohler Er, Adam L., McClelland P., Graham L., Hathaway D. Detection of osteopontin in calcified human aortic valves. Arterioscler Thromb Vasc Biol 1997, 17:547-552.
12. Mohler Er, Chawla M., Chang A., et al. Identification and characterization of calcifying valve cells from human and canine aortic valves. JHeart Valve Dis 1999, 8:254-260.
13. Miller J.D., Weiss R.M., Heistad D.D. Calcific aortic valve stenosis: methods, models, and mechanisms. Circ Res 2011, 108:1392-1412.
14. O'Brien K., Kuusisto J., Reichenbach D., et al. Osteopontin is expressed in human aortic valvular lesions. Circulation 1995, 92:2163-2168.
15. Jono S., McKee M.D., Murry C.E., et al. Phosphate regulation of vascular smooth muscle cell calcification. Circ Res 2000, 87:E10-E17.
16. Linefsky J.P., O'Brien K.D., Katz R., et al. Association of serum phosphate levels with aortic valve sclerosis and annular calcification: the cardiovascular health study. JAm Coll Cardiol 2011, 58:291-297.
17. Bild D., Bluemke D., Burke G., et al. Multi-ethnic study of atherosclerosis: objectives and design. Am J Epidemiol 2002, 156:871-881.
18. Cushman M., Cornell E., Howard P., Bovill E., Tracy R. Laboratory methods and quality assurance in the Cardiovascular Health Study. Clin Chem 1995, 41:264-270.
19. Stevens L., Coresh J., Schmid C., et al. Estimating GFR using serum cystatin C alone and in combination with serum creatinine: a pooled analysis of 3,418 individuals with CKD. Am J Kidney Dis 2008, 51:395-406.
20. Friedewald W.T., Levy R.I., Fredrickson D.S. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972, 18:499-502.
21. Budoff M., Mao S., Takasu J., Shavelle D., Zhao X., O'Brien K. Reproducibility of electron-beam CT measures of aortic valve calcification. Acad Radiol 2002, 9:1122-1127.
22. Budoff M., Takasu J., Katz R., et al. Reproducibility of CT measurements of aortic valve calcification, mitral annulus calcification, and aortic wall calcification in the multi-ethnic study of atherosclerosis. Acad Radiol 2006, 13:166-172.
23. Budoff M., Katz R., Wong N., et al. Effect of scanner type on the reproducibility of extracoronary measures of calcification: the multi-ethnic study of atherosclerosis. Acad Radiol 2007, 14:1043-1049.
24. Agatston A., Janowitz W., Hildner F., Zusmer N., Viamonte M.J., Detrano R. Quantification of coronary artery calcium using ultrafast computed tomography. JAm Coll Cardiol 1990, 15:827-832.
25. Van Buuren S., Groothuis-Oudshoorn K. M.I.C.E. Multivariate imputation by chained equations in R. JStat Softw 2011, 43:1-67.
26. Rubin D. Multiple Imputation for Nonresponse in Surveys 1987, Wiley, New York.
27. Owens D.S., Otto C.M. Is it time for a new paradigm in calcific aortic valve disease?. JACC Cardiovasc Imaging 2009, 2:928-930.
28. Owens D.S., Katz R., Takasu J., Kronmal R., Budoff M.J., O'Brien K.D. Incidence and progression of aortic valve calcium in the Multi-ethnic Study of Atherosclerosis (MESA). Am J Cardiol 2010, 105:701-708.
29. Miller J.D., Weiss R.M., Serrano K.M., et al. Evidence for active regulation of pro-osteogenic signaling in advanced aortic valve disease. Arterioscler Thromb Vasc Biol 2010, 30:2482-2486.
30. Mohler Er, Gannon F., Reynolds C., Zimmerman R., Keane M., Kaplan F. Bone formation and inflammation in cardiac valves. Circulation 2001, 103:1522-1528.
31. Rajamannan N., Subramaniam M., Rickard D., et al. Human aortic valve calcification is associated with an osteoblast phenotype. Circulation 2003, 107:2181-2184.
32. O'Brien K., Shavelle D., Caulfield M., et al. Association of angiotensin-converting enzyme with low-density lipoprotein in aortic valvular lesions and in human plasma. Circulation 2002, 106:2224-2230.
33. Babu A.N., Meng X., Zou N., et al. Lipopolysaccharide stimulation of human aortic valve interstitial cells activates inflammation and osteogenesis. Ann Thorac Surg 2008, 86:71-76.
34. Li X., Yang H., Giachelli C. Role of the sodium-dependent phosphate cotransporter, Pit-1, in vascular smooth muscle cell calcification. Circ Res 2006, 98:905-912.
35. El Husseini D., Boulanger M.C., Fournier D., et al. High expression of the Pi-transporter SLC20A1/Pit1 in calcific aortic valve disease promotes mineralization through regulation of Akt-1. PLoS One 2013, 8:e53393.
36. Shuto E., Taketani Y., Tanaka R., et al. Dietary phosphorus acutely impairs endothelial function. JAm Soc Nephrol 2009, 20:1504-1512.
37. Byon C.H., Javed A., Dai Q., et al. Oxidative stress induces vascular calcification through modulation of the osteogenic transcription factor Runx2 by AKT signaling. JBiol Chem 2008, 283:15319-15327.
38. Miller J.D., Chu Y., Brooks R.M., Richenbacher W.E., Peña-Silva R., Heistad D.D. Dysregulation of antioxidant mechanisms contributes to increased oxidative stress in calcific aortic valvular stenosis in humans. JAm Coll Cardiol 2008, 52:843-850.
39. Liberman M., Bassi E., Martinatti M.K., et al. Oxidant generation predominates around calcifying foci and enhances progression of aortic valve calcification. Arterioscler Thromb Vasc Biol 2008, 28:463-470.
40. Kirkpantur A., Balci M., Gurbuz O.A., et al. Serum fibroblast growth factor-23 (FGF-23) levels are independently associated with left ventricular mass and myocardial performance index in maintenance haemodialysis patients. Nephrol Dial Transplant 2011, 26:1346-1354.
41. El-Abbadi M., Pai A., Leaf E., et al. Phosphate feeding induces arterial medial calcification in uremic mice: role of serum phosphorus, fibroblast growth factor-23, and osteopontin. Kidney Int 2009, 75:1297-1307.
42. Gökçe C., Gökçe O., Baydinç C., et al. Use of random urine samples to estimate total urinary calcium and phosphate excretion. Arch Intern Med 1991, 151:1587-1588.